🇺🇸 FDA
Patent

US 12226610

Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions

granted A61KA61K31/167A61K31/445

Quick answer

US patent 12226610 (Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions) held by Pacira Pharmaceuticals, Inc. expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pacira Pharmaceuticals, Inc.
Grant date
Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/167, A61K31/445, A61K9/0019, A61K9/0085